Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue for chronic neuropathic pain
2008-006410-20Phase 2Active
- Sponsor
- Institutionen för kirurgiska vetenskaper
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylene blue in Neuralgia (2 arms), sponsored by Institutionen för kirurgiska vetenskaper. Primary endpoint: Pain reduction after infusion. Started Nov 2008; status: active.
02
Drugs
methylene blue
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2008-006410-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006410-20.